IBDEI0TE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14229,1,2,0)
 ;;=2^Repair of Nail Bed
 ;;^UTILITY(U,$J,358.3,14229,1,3,0)
 ;;=3^11760
 ;;^UTILITY(U,$J,358.3,14230,0)
 ;;=11765^^75^874^11^^^^1
 ;;^UTILITY(U,$J,358.3,14230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14230,1,2,0)
 ;;=2^Wedge Excision of Skin Nail Fold
 ;;^UTILITY(U,$J,358.3,14230,1,3,0)
 ;;=3^11765
 ;;^UTILITY(U,$J,358.3,14231,0)
 ;;=11055^^75^875^1^^^^1
 ;;^UTILITY(U,$J,358.3,14231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14231,1,2,0)
 ;;=2^Trim Skin Lesion, Single Lesion
 ;;^UTILITY(U,$J,358.3,14231,1,3,0)
 ;;=3^11055
 ;;^UTILITY(U,$J,358.3,14232,0)
 ;;=11056^^75^875^2^^^^1
 ;;^UTILITY(U,$J,358.3,14232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14232,1,2,0)
 ;;=2^Trim Skin Lesion,2-4 Lesions
 ;;^UTILITY(U,$J,358.3,14232,1,3,0)
 ;;=3^11056
 ;;^UTILITY(U,$J,358.3,14233,0)
 ;;=11057^^75^875^3^^^^1
 ;;^UTILITY(U,$J,358.3,14233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14233,1,2,0)
 ;;=2^Trim Skin Lesions, Over 4
 ;;^UTILITY(U,$J,358.3,14233,1,3,0)
 ;;=3^11057
 ;;^UTILITY(U,$J,358.3,14234,0)
 ;;=17000^^75^876^1^^^^1
 ;;^UTILITY(U,$J,358.3,14234,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14234,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesion; 1st lesion
 ;;^UTILITY(U,$J,358.3,14234,1,3,0)
 ;;=3^17000
 ;;^UTILITY(U,$J,358.3,14235,0)
 ;;=17003^^75^876^2^^^^1
 ;;^UTILITY(U,$J,358.3,14235,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14235,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesions; 2nd-14th lesion, each
 ;;^UTILITY(U,$J,358.3,14235,1,3,0)
 ;;=3^17003
 ;;^UTILITY(U,$J,358.3,14236,0)
 ;;=17004^^75^876^3^^^^1
 ;;^UTILITY(U,$J,358.3,14236,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14236,1,2,0)
 ;;=2^Destruction, all benign or premalignant lesions other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions
 ;;^UTILITY(U,$J,358.3,14236,1,3,0)
 ;;=3^17004
 ;;^UTILITY(U,$J,358.3,14237,0)
 ;;=17110^^75^876^4^^^^1
 ;;^UTILITY(U,$J,358.3,14237,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14237,1,2,0)
 ;;=2^Destruction, of flat warts, molluscum contagiosum, or milia; up to 14 lesions
 ;;^UTILITY(U,$J,358.3,14237,1,3,0)
 ;;=3^17110
 ;;^UTILITY(U,$J,358.3,14238,0)
 ;;=17111^^75^876^5^^^^1
 ;;^UTILITY(U,$J,358.3,14238,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14238,1,2,0)
 ;;=2^Destruction, of flat warts, molluscum contagiosum, or milia; 15 or more lesions
 ;;^UTILITY(U,$J,358.3,14238,1,3,0)
 ;;=3^17111
 ;;^UTILITY(U,$J,358.3,14239,0)
 ;;=17250^^75^876^6^^^^1
 ;;^UTILITY(U,$J,358.3,14239,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14239,1,2,0)
 ;;=2^Chemical cauterization of granulation tissue
 ;;^UTILITY(U,$J,358.3,14239,1,3,0)
 ;;=3^17250
 ;;^UTILITY(U,$J,358.3,14240,0)
 ;;=11400^^75^877^1^^^^1
 ;;^UTILITY(U,$J,358.3,14240,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14240,1,2,0)
 ;;=2^Exc Benign Lesion-Trunk,Legs;0.5cm or less
 ;;^UTILITY(U,$J,358.3,14240,1,3,0)
 ;;=3^11400
 ;;^UTILITY(U,$J,358.3,14241,0)
 ;;=11401^^75^877^2^^^^1
 ;;^UTILITY(U,$J,358.3,14241,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14241,1,2,0)
 ;;=2^Exc Benign Lesion-Trunk,Legs;0.6cm-1.0cm
 ;;^UTILITY(U,$J,358.3,14241,1,3,0)
 ;;=3^11401
 ;;^UTILITY(U,$J,358.3,14242,0)
 ;;=11402^^75^877^3^^^^1
 ;;^UTILITY(U,$J,358.3,14242,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14242,1,2,0)
 ;;=2^Exc Benign Lesion-Trunk,Legs;1.1cm-2.0cm
 ;;^UTILITY(U,$J,358.3,14242,1,3,0)
 ;;=3^11402
 ;;^UTILITY(U,$J,358.3,14243,0)
 ;;=11403^^75^877^4^^^^1
 ;;
 ;;$END ROU IBDEI0TE
